DORZAGLIOTIN
China's Hua Medicine has figured out how to cure type 2 diabetes and achieve long-term, stable remission.
After 10 years of research in China, Dorzaglatin – the world's first glucokinase modulator from Hua Medicine, has been approved.
The drug is registered and manufactured in China.
Bayer has obtained the rights to manufacture and sell it worldwide (except in China).
Dorzaglatin restores glucose balance and paves the way for long-term remission of type II diabetes.
For more information, click on the buttons above.
The drug is registered and manufactured in China.
Bayer has obtained the rights to manufacture and sell it worldwide (except in China).
Dorzaglatin restores glucose balance and paves the way for long-term remission of type II diabetes.
For more information, click on the buttons above.
